REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/09/2026
Back to search
Official data from USPTO
MALDI PHARMAPULSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MALDI PHARMAPULSE
ST13
US500000079185165Class
9, 10, 42
Filing
79185165
Registration
5197716
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
05/10/2026
Classification
Registered
Trademark type
Word
Nice classes
9, 10, 42
Filing date
01/13/2016
Registration date
05/09/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2024
Last transaction
05/10/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Bremen, DE
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
M10
Holders and representatives
Holders
Bruker Daltonics GmbH & Co. KG
Bruker Daltonik GmbH
Representatives
Paul G. Novak Orbit IP LLP
Technical classification
Nice Classes
Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Mass spectrometersparticularly time-of-flight mass spectrometer; computer programs and software for assisting in the development of functional assays in the biochemical field; computer programs and computer software for operating mass spectrometersparticularly time-of-flight mass spectrometer; computer programs and computer software for processingevaluating and displaying data recorded by mass spectrometers
Class 10
Medical and veterinary diagnostic instrumentsin particular mass spectrometers for examining pharmaceutical and biological samples
Class 42
Scientific and technological services for using mass spectrometersin particular time-of-flight mass spectrometersin medicine research and medicine developmentmedical and scientific research in the field of developing functional biochemical assays; scientific and technological services for mass-spectrometric high-throughput analysis of samplesin particular pharmaceutical and biological samples for label-free detection of native substrates and products in functional biochemical assays; design and development of computer programs and computer software for use with the aforesaid goods and services
Publications
History of USPTO decisions and trademark events.
42 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/20/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/23/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/26/2024
INPC
INVALIDATION PROCESSED
09/26/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/25/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/24/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
01/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/16/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
05/09/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/09/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/20/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/29/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/10/2017
FIMP
FINAL DISPOSITION PROCESSED
08/10/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/09/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/31/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2017
PUBO
PUBLISHED FOR OPPOSITION
02/21/2017
GPNX
NOTIFICATION PROCESSED BY IB
02/17/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/01/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/09/2016
GNSL
LETTER OF SUSPENSION E-MAILED
11/09/2016
CNSL
SUSPENSION LETTER WRITTEN
11/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2016
RFNT
REFUSAL PROCESSED BY IB
05/19/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/02/2016
RFRR
REFUSAL PROCESSED BY MPU
05/02/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/01/2016
CNRT
NON-FINAL ACTION WRITTEN
04/30/2016
DOCK
ASSIGNED TO EXAMINER
04/22/2016
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2016
Continuous trademark protection
Get notified about every new filing that threatens MALDI PHARMAPULSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.